STABILIZED OPHTHALMIC GALACTOMANNAN FORMULATIONS

The present invention relates to viscosity stabilized ophthalmic formulations and ophthalmic formulations suitable for drug delivery. The formulations comprise galactomannans such as guar or hydroxypropyl guar and a borate source such as boric acid. The formulations further comprise a diol alcohol s...

Full description

Saved in:
Bibliographic Details
Main Authors KETELSON, HOWARD, ALLEN, DAVIS, JAMES, W, MEADOWS, DAVID, L
Format Patent
LanguageEnglish
French
Published 10.11.2011
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention relates to viscosity stabilized ophthalmic formulations and ophthalmic formulations suitable for drug delivery. The formulations comprise galactomannans such as guar or hydroxypropyl guar and a borate source such as boric acid. The formulations further comprise a diol alcohol such as sorbitol and, optionally, a pharmaceutically acceptable divalent cation salt such as magnesium chloride. La présente invention concerne des formulations ophtalmiques à viscosité stabilisée et des formulations ophtalmiques adaptées pour l'administration de médicament. Les formulations comprennent des galactomannanes tels que le guar ou l'hydroxypropyl-guar et une source de borate telle que l'acide borique. Les formulations comprennent en outre un alcool diol tel que le sorbitol et, facultativement, un sel de cation divalent pharmaceutiquement acceptable tel que le chlorure de magnésium.
AbstractList The present invention relates to viscosity stabilized ophthalmic formulations and ophthalmic formulations suitable for drug delivery. The formulations comprise galactomannans such as guar or hydroxypropyl guar and a borate source such as boric acid. The formulations further comprise a diol alcohol such as sorbitol and, optionally, a pharmaceutically acceptable divalent cation salt such as magnesium chloride. La présente invention concerne des formulations ophtalmiques à viscosité stabilisée et des formulations ophtalmiques adaptées pour l'administration de médicament. Les formulations comprennent des galactomannanes tels que le guar ou l'hydroxypropyl-guar et une source de borate telle que l'acide borique. Les formulations comprennent en outre un alcool diol tel que le sorbitol et, facultativement, un sel de cation divalent pharmaceutiquement acceptable tel que le chlorure de magnésium.
Author KETELSON, HOWARD, ALLEN
MEADOWS, DAVID, L
DAVIS, JAMES, W
Author_xml – fullname: KETELSON, HOWARD, ALLEN
– fullname: DAVIS, JAMES, W
– fullname: MEADOWS, DAVID, L
BookMark eNrjYmDJy89L5WQwCA5xdPL08YxydVHwD_AI8XD08fV0VnB39HF0DvH3dfTzc_RTcPMP8g31cQzx9PcL5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8eH-RgaGhoYmBkYGxo5GxsSpAgDpFiku
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate FORMULATIONS OPHTALMIQUES STABILISÉES DE GALACTOMANNANE
ExternalDocumentID WO2011140203A2
GroupedDBID EVB
ID FETCH-epo_espacenet_WO2011140203A23
IEDL.DBID EVB
IngestDate Fri Jul 19 13:03:36 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_WO2011140203A23
Notes Application Number: WO2011US35165
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20111110&DB=EPODOC&CC=WO&NR=2011140203A2
ParticipantIDs epo_espacenet_WO2011140203A2
PublicationCentury 2000
PublicationDate 20111110
PublicationDateYYYYMMDD 2011-11-10
PublicationDate_xml – month: 11
  year: 2011
  text: 20111110
  day: 10
PublicationDecade 2010
PublicationYear 2011
RelatedCompanies KETELSON, HOWARD, ALLEN
ALCON RESEARCH, LTD
MEADOWS, DAVID, L
DAVIS, JAMES, W
RelatedCompanies_xml – name: ALCON RESEARCH, LTD
– name: DAVIS, JAMES, W
– name: MEADOWS, DAVID, L
– name: KETELSON, HOWARD, ALLEN
Score 2.8321078
Snippet The present invention relates to viscosity stabilized ophthalmic formulations and ophthalmic formulations suitable for drug delivery. The formulations comprise...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title STABILIZED OPHTHALMIC GALACTOMANNAN FORMULATIONS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20111110&DB=EPODOC&locale=&CC=WO&NR=2011140203A2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-LHlILSt2K7xtI-DEm_7KRfaKfDl9G0GQjSDVfx3_earbqn5SkkkI-Du8vvkvsF4FYzC4vpBqITxhGgzDhR8nxAFBOP5iWxzIIL3oIoNoIxeZrcTzrw2ebCCJ7QH0GOiBpVoL7Xwl4v_oNYrnhbubxjH9g0f_CzoSuXbbgPiyq79tBLEzdxZMdB3CbHz6u-BivpFA32TnOQbpj2vVe7yUtZbDoV_xB2Uxyvqo-gw6se7Dvt32s92IvWV95YXWvf8hjUl4zao3D07rlSkgZZQEMUovRIQ-pkSUTjmMYSorpoHK6yg0_gxvcyJ1Bw6unfTqdvyeY69VPoVvOKn4GkC6Z2YjCdlcRAIWqlZjE-yA02y9V8cA79bSNdbO--hAMRKhUpdn3o1l_f_Ap9bc2uhYh-ATiwfKg
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTsWPqQWlb8O1jXV9GJKlrZ32Y2imw5fSrBkI0g1X8d_3lm26p-Up5OCSHNwlv8vdBeDaaI8cYdmIToREgDKWpJllJmm28WqeE6c9kqpuQRTbwYA8Dm-HFfhc5cKoOqE_qjgiatQI9b1U9nr678RyVWzl7EZ84NDk3ucdV89X7j5sLd3tdrx-4iZMZwxxmx4_L2hzrGRRNNhbdwgKFVh67c7zUqbrh4q_B9t95FeU-1CRRR1qbPX3Wh12ouWTN3aX2jc7gNYLp91e2Hv3XC3pBzygIQpRe6AhZTyJaBzTWENUFw3CRXbwIVz5HmdBE6dO_3aaviXr67SOoFpMCnkMmqUqtRNbWCInNgrRyA1HSDOzxThrZeYJNDZxOt1MvoRawKMwDXvx0xnsKrepinRrQLX8-pbneO6W4kKJ6xcyM3-S
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=STABILIZED+OPHTHALMIC+GALACTOMANNAN+FORMULATIONS&rft.inventor=KETELSON%2C+HOWARD%2C+ALLEN&rft.inventor=DAVIS%2C+JAMES%2C+W&rft.inventor=MEADOWS%2C+DAVID%2C+L&rft.date=2011-11-10&rft.externalDBID=A2&rft.externalDocID=WO2011140203A2